advertisement

Topcon

De Francesco T 10

Showing records 1 to 10 | Display all abstracts from De Francesco T

109661 All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure
Schlenker MB
American Journal of Ophthalmology 2023; 255: 125-140
109727 Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye
Huang MJ
Journal of Cataract and Refractive Surgery 2023; 49: 764
109258 Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin Microstent
Hussein IM; De Francesco T
Ophthalmology. Glaucoma 2023; 6: 580-591
109661 All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure
Armstrong JJ
American Journal of Ophthalmology 2023; 255: 125-140
109727 Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye
Samuelson TW
Journal of Cataract and Refractive Surgery 2023; 49: 764
109661 All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure
De Francesco T
American Journal of Ophthalmology 2023; 255: 125-140
109727 Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye
De Francesco T
Journal of Cataract and Refractive Surgery 2023; 49: 764
109258 Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin Microstent
Ahmed IIK
Ophthalmology. Glaucoma 2023; 6: 580-591
109661 All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure
Ahmed IIK
American Journal of Ophthalmology 2023; 255: 125-140
109727 Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye
Levin A; Sieck E; Gazzard G; Porter M; Gallardo M; Chang RT; Liu WW; Chaya C; Gulati S; Shah M
Journal of Cataract and Refractive Surgery 2023; 49: 764

Issue 24-1

Change Issue


advertisement

Oculus